Your common diabetes drug may impact cancer — here's what new study shows
By LiveMint-Science

A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may affect cancer growth.
By LiveMint-Science

The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026.

A surge led by electronics and marine products lifts India’s shipments to China amid easing tensions and global supply-chain shifts, even as experts warn the gains are narrow and the trade deficit continues to widen

As it lines up an initial public offering, Duroflex Group enters a tougher arena shaped by new-age rivals, private equity capital and shifting consumer behaviour. The listing comes as organized brands jostle for share in a still-fragmented mattress and furniture market, where scale matters.

Strong Q3 US GDP keeps Fed cautious as markets reassess rate-cut expectations









